Preparing for China · patient guide

Crohn's Disease in China: Planning Review Alongside Current Local Care

You can ask a Chinese hospital team to review your Crohn's disease records while you continue your current treatment at home. The review is an opinion, not an instruction to stop or switch anything. Your existing gastroenterologist keeps day-to-day responsibility unless you and the receiving team agree otherwise in writing.

Go to the practical guidance ↓
AI illustration: A doctor discusses medical information with a patient and another medical professional in a consultation room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a records-based review can and cannot decide

A review built on your existing endoscopy, pathology and treatment history can help a Chinese gastroenterology team understand your disease pattern and comment on whether any further assessment looks reasonable. It cannot examine you, and it cannot confirm how you will respond to a different approach. Crohn's disease care can involve medicines or surgery, and the treating team selects an individual approach, so any opinion depends on the records supplied and the assumptions made from them.

That distinction matters when you are already in treatment. A remote opinion is not a replacement for your current clinician's assessment, and it does not authorise you to change medicines. If your symptoms are worsening, seek local care first rather than waiting for an overseas reply.

Why the two teams should not be asked to compete

A frequent way cross-border Crohn's planning goes wrong is presenting the enquiry as a choice between your current doctor and a Chinese hospital. That framing invites each side to defend its position, and you end up holding two plans that were never compared on the same evidence.

A better approach is to ask the Chinese team a defined question: given these records, what would you want to know before offering an opinion, and what would you need to see in person? That keeps your local treatment running while the review proceeds, and it gives you something concrete to discuss with your own gastroenterologist.

If the two opinions differ, the difference itself is useful information. Ask each side what specific finding would change its view. A disagreement about a scan, a pathology report or the timing of a procedure is easier to resolve than a general disagreement about approach.

The records that actually move a Crohn's review forward

A short summary is enough for a first enquiry. You do not need to send a complete archive before anyone will speak to you. What helps most is a clear timeline: when the diagnosis was confirmed, which parts of the bowel are involved, what medicines you have taken and whether any surgery has been performed.

Endoscopy and pathology reports carry particular weight because they describe the disease directly rather than through symptoms. If a report is missing, say so rather than substituting a later summary. The reviewing clinician needs to know what is documented and what is not.

Previous medicines matter as much as current ones. A list of what was tried, in what order, and why it was changed gives the reviewer a picture of your disease course. You do not need to interpret those changes; just record them accurately and let the clinician assess them.

  • Diagnosis date and how it was confirmed
  • Endoscopy and pathology reports, with dates
  • Current medicines and the reason for each
  • Previous medicines and why they were stopped or changed
  • Any bowel surgery, with the operation note if available
  • Recent imaging and blood results
  • Your main question in one or two sentences

How to keep your current treatment uninterrupted

State clearly in your enquiry that you are not asking to stop or replace your current treatment. Ask the reviewing team to give its opinion in a form you can share with your own gastroenterologist, so the decision stays with the clinician who knows you.

If a Chinese team suggests a change, treat that as a question for your local clinician, not an instruction. Your current prescriber is the person who can assess whether a change is safe for you, and that assessment depends on your full history, not only the records you sent abroad.

Do not pause or alter any medicine while an enquiry is in progress. If you become unwell, contact local services rather than waiting for a reply from overseas.

What to confirm before you consider travelling

A favourable review does not mean a hospital has accepted you, and it does not confirm that a particular treatment is available to you in China. Those are separate decisions made by the receiving hospital after it sees your records and, where relevant, examines you.

Before committing to travel, ask the hospital what it would need to assess you in person, what the visit would involve, and who would hold responsibility for your care during and after the visit. Ask how your current treatment would continue while you are away, and who would manage it on your return.

Ask for the written scope of any quotation you receive: what is included, what is excluded, what remains undecided, and who is paid for each part. Coordination fees and hospital medical fees are separate, and the hospital's own charges are set by the hospital.

A practical next step

Start with a short summary rather than a complete archive. Write down your main question in one or two sentences, gather the reports listed above, and send that summary through the enquiry form, email or WhatsApp. The team will tell you what is missing and what the relevant next step looks like. An initial enquiry is free, and it does not require buying a proxy consultation.

The point of the exercise is not to collect a second opinion that sits unused in a folder. It is to give your own gastroenterologist something specific to react to. When the Chinese team replies, take that reply to your local clinician and ask whether anything in it changes the picture, and if not, why not. That conversation is where the value of a cross-border review actually lands.

Keep the two roles separate in your own mind as well. The Chinese team is commenting on records you chose to send. Your local clinician is examining you, ordering your tests and holding responsibility for your day-to-day treatment. Neither role replaces the other, and a review is not a verdict on the care you are already receiving.

If the review raises a question your local clinician cannot answer from the records alone, ask what would settle it. That might be a repeat endoscopy, a pathology re-read, or simply a longer period of observation. Whatever the answer, the decision about whether to act on it belongs with the clinician who can see you.

One practical habit helps here: keep a single dated note of what you sent, to whom, and what came back. If you later approach a different hospital, or return to the same one after a change in your condition, that note saves you from reconstructing the history from memory and from sending inconsistent summaries to different teams.

You do not need to resolve everything before making contact. A short summary, a clear question and an honest statement of what is missing is enough to begin. The team can then tell you whether a records-based opinion is the right route for your situation or whether something else, including local assessment first, makes more sense.

Your local gastroenterologist remains responsible for your treatment unless you and a receiving team agree otherwise in writing. Nothing in an overseas review changes that, and no reply from abroad should be treated as permission to alter a medicine or skip a scheduled appointment.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. gastroenterology
  2. Related treatment reference
  3. NIDDK: Treatment for Crohn's Disease

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.